Analysis of cases that went through dispute resolution found the final allowed amount averaged $635—an amount significantly lower than the 80th percentile benchmark ($1944) and in line with the median in-network allowed amount benchmark ($634).
Other featured articles
Revising Payment to Medicare Advantage Plans to Reflect the Rapid Growth in Enrollment
Medicare Advantage enrollment is projected to represent the majority of Medicare beneficiaries enrolled in both Part A and Part B by 2023. This event will discuss this trend and the financial implications.
Women and Adolescent Girls Face Barriers Accessing Contraceptives – Even in Blue States Like California
States dedicated to ensuring women receive the care they need should fix existing gaps in contraceptive access.
It’s Time to Let Pharmacists Prescribe COVID-Fighting Pills Like Paxlovid
To reduce hospitalization and death, pharmacists should have the same prescribing abilities as doctors for COVID anti-viral drugs Paxlovid and Lagevrio, USC School of Pharmacy
Dean Vassilios Papadopoulos writes in a new MarketWatch op-ed.
The Unequal Causes and Costs of Dementia
Dementia and its costs aren’t equally borne by all populations. Studies indicate that, compared to older non-Hispanic white adults, older Black adults are about twice as likely to have dementia, and older Hispanic adults about one and one-half times as likely.
The Leonard D. Schaeffer Center for Health Policy & Economics, one of the nation’s premier policy centers, measurably improves value in health through evidence-based policy solutions, research excellence, and private- and public-sector engagement.about
More from Schaeffer
Our Policy Areas
From aging to drug pricing to health disparities, Schaeffer Center experts are advancing research to inform policy. Learn about the areas we work in.Learn More
Work & Study at USC
The Schaeffer Center develops innovators for positions in higher education, research, government and healthcare through degree programs and postgraduate opportunities.Learn More
Revising Payment to Medicare Advantage Plans to Reflect the Rapid Growth in EnrollmentMedicare Advantage enrollment is projected to represent the majority of Medicare beneficiaries enrolled in both Part A and Part B by 2023. This event will discuss this trend and the financial implications.Date of event:
The Science of Alzheimer’s Disease and Related Dementias (ADRD) for Social Scientists ProgramThis two-day program aims to provide social science researchers with biomedical and clinical foundations of ADRD.Date of event: